Skip to content

Role of Patra-agni swedana (an Ayurvedic procedure) in the management of Frozen shoulder.

Randomized controlled clinical evaluation of Tila Taila Abhyanga followed by Patra Agni Swedana (a modified Agnikarma procedure) in Avabahuka (adhesive capsulitis of shoulder)

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051605
Enrollment
70
Registered
2023-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

None listed

Sponsors

NEIAH, Shillong
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient who are willing to participate in the study and ready to give a written informed consent. 2. Subjects of either sex in the age group of 40 years to 70 years. 3. Pain and stiffness with motion in the effected shoulder joint. 4. Limitation of passive movement in the glenohumeral joint compared with the unaffected side, more than 30 degrees for at least two of these three movements: forward flexion, abduction or external rotation.

Exclusion criteria

Exclusion criteria: 1. The subjects who are known to have congenital abnormality of the shoulder joint and/or upper limb, osteoarthritis of shoulder joint, rheumatoid arthritis and other autoimmune diseases, malignancies, history of any trauma, fracture or dislocation related to the shoulder joint, or surgical history to the joint. 2. Patient who has been administered intra-articular injection into the affected shoulder joint or invasive measures have been performed at the affected joint or systemic medication with corticosteroids during the preceding 3 months. 3. Patients with diabetes and hyper or hypo thyroidism. 4. Pregnant or lactating women. 5. Patients with an acute mental disorder, a serious acute organic disease, or any serious comorbidity that made it impossible to participate in the trial interventions.

Design outcomes

Primary

MeasureTime frame
improvement in range of movement of shoulder jointTimepoint: 0-day, 15th day and 30th day

Secondary

MeasureTime frame
assessment of any adverse drug reactionTimepoint: 30 days

Countries

India

Contacts

Public ContactAbhishek Bhattacharjee

North Eastern Institute of Ayurveda and Homoeopathy, Shillong

drabhishekb@gmail.com8876059293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026